Harris & Harris Group (NASDAQ:TURN) is a specialty venture capital firm focused on early-stage companies that harness transformative technologies. Since its founding in 1993 and its subsequent licensing as a small business investment company (SBIC) by the U.S. Small Business Administration, the firm has partnered with entrepreneurs to accelerate the development and commercialization of disruptive innovations. Headquartered in Chicago, Harris & Harris Group combines deep scientific expertise with a rigorous investment process to identify opportunities that address large and growing markets.
The firm’s investment strategy spans three primary verticals: Digital Transformation, Life Sciences & Healthcare, and Physical Sciences. In the Digital Transformation arena, Harris & Harris Group backs companies developing advanced analytics, artificial intelligence, and cybersecurity solutions. On the Life Sciences front, the firm supports novel therapeutics, medical devices, and diagnostics that aim to improve patient outcomes and reduce healthcare costs. In Physical Sciences, portfolio companies work on advanced materials, energy storage, and precision manufacturing technologies.
Harris & Harris Group typically leads or co-leads funding rounds at the Series A or Series B stage, providing not only capital but also strategic guidance, industry connections, and operational support. The firm’s hands-on approach includes active board participation and collaboration with entrepreneurs to overcome technical and commercialization challenges. Over the years, Harris & Harris Group has built a diversified portfolio of companies that have gone on to secure follow-on financing, strategic partnerships, and market entry milestones.
Guided by CEO and President Celeste Barrone, along with an experienced investment team of scientists, engineers, and industry veterans, the firm remains committed to fostering innovation domestically and abroad. While most investments are U.S.-based, Harris & Harris Group evaluates technology entrepreneurs globally, seeking ventures that can benefit from its deep domain expertise and network. As a publicly traded venture investor, the firm offers a unique vehicle for investors to gain exposure to an emerging growth portfolio of cutting-edge technology enterprises.
AI Generated. May Contain Errors.
Free TURN Stock Alerts